Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Atea Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 104 | 1 | 142 | +39 |
| Shares | 58.9M | 72.2K | 56.8M | −2.00M (−3.4%) |
| Value | $1.27B | $1.55M | $1.99B | +$728.2M (+57.6%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (56)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (17)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 1,265,631 | $27.2M |
| Healthcare of Ontario Pension Plan Trust Fund | 615,500 | $13.2M |
| Sectoral Asset Management Inc | 538,884 | $11.6M |
| Balyasny Asset Management LLC | 399,227 | $8.57M |
| Ally Bridge Group (NY) LLC | 373,288 | $8.02M |
| Redmile Group, LLC | 237,360 | $5.10M |
| Fan Yu | 143,867 | $3.09M |
| Prudential Financial Inc | 66,875 | $1.44M |
| Ameraudi Asset Management, Inc. | 65,000 | $1.40M |
| J. Goldman & Co LP | 37,313 | $801.0K |
| Engineers Gate Manager LP | 22,848 | $491.0K |
| Occudo Quantitative Strategies LP | 20,866 | $448.0K |
| Verition Fund Management LLC | 14,375 | $309.0K |
| Two Sigma Advisers, LP | 13,900 | $299.0K |
| Advisory Services Network, LLC | 4,870 | $105.0K |
| Bellwether Advisors, LLC | 116 | $2.00K |
| Captrust Financial Advisors | 26 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Atea Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 72,193 | $1.55M |